| Product Name | MF | CAS | Details |
|---|
| Sorafenib Impurity 34 | C8H9ClN2O | 114780-06-2 | Details |
| Azelastine Impurity 2 | C22H24ClN3O·HCl | 153408-27-6 | Details |
| Sorafenib Impurity 32 | C8H3ClF3NO | 88330-63-6 | Details |
| Enzalutamide Impurity 2 | C20H14F4N4O2S | 1242137-16-1 | Details |
| Enzalutamide Impurity 1 | C20H13F4N3O3S | 1242137-15-0 | Details |
| Enzalutamide Impurity 3 | C21H16F4N4O3 | 1242137-18-3 | Details |
| Azelastine Impurity 6(Azelastine EP Impurity D) | C15H11ClN2O | 53242-88-9 | Details |
| Emtricitabine Impurity 1 | C8H9FN2O4S | 145986-11-4 | Details |
| Enzalutamide | C21H16F4N4O2S | 915087-33-1 | Details |
| Emtricitabine | C8H10FN3O3S | 143491-57-0 | Details |
| Azelastine Impurity 4(Azelastine EP Impurity B) | C14H22ClN3O | 117078-69-0 | Details |
| Cinacalcet | C22H23ClF3N | 364782-34-3 | Details |
| Penehyclidine | C20H29NO2 | 87827-02-9 | Details |
| Bromhexine Impurity 5（Bromhexine EP Impurity E） | C15H21Br2N2+ | 1661064-00-1 | Details |
| Cinacalcet Impurity 1 ((S)-Isomer)（Cinacalcet USP Related Compound D HCl) | C22H23ClF3N | 1217809-88-5 | Details |
| Cinacalcet Impurity 3 | C22H20F3N | 955373-56-5 | Details |
| Cinacalcet Impurity 2（Cinacalcet USP RC C） | C22H23ClF3N | 1428118-39-1 | Details |
| Cinacalcet Impurity 5（Cinacalcet USP RC B） | C32H31F6N | 1271930-15-4 | Details |
| Cinacalcet Impurity 13 | C22H25ClF3N | 1622173-72-1 | Details |
| Cinacalcet Impurity 4 | C10H9F3 | 1813-96-3 | Details |
| Cinacalcet Impurity 8 | C12H13N | 3886-70-2 | Details |
| Cinacalcet Impurity 6 | C22H25N | 253337-60-9 | Details |
| Ambroxol Impurity 4（Ambroxol EP Impurity A） | C7H7Br2NO | 50739-76-9 | Details |
| Bromhexine Impurity 3（Bromhexine EP Impurity C） | C14H22N2 | 57365-08-9 | Details |
| Bromhexine Impurity 4（Bromhexine EP Impurity D） | C14H21BrN2 | 132004-28-5 | Details |
| Cinacalcet Impurity 10 | C22H24F3N | 802918-47-4 | Details |
| Salmeterol Impurity 2（Salmeterol EP Impurity A ） | C19H25NO3 | 1798014-51-3 | Details |
| Salmeterol Impurity 3（Salmeterol EP Impurity B ） | C23H33NO4 | 94749-02-7 | Details |
| Allisartan Isoproxil Impurity 15 | C22H23ClF3N | 2200269-28-7 | Details |
| Salmeterol Impurity 4（Salmeterol EP Impurity C ） | C24H35NO4 | 94749-11-8 | Details |
| Celecoxib Impurity 13 | C18H16F3N3O2S | 170570-09-9 | Details |
| Celecoxib Impurity 11 | C15H17N3O2S | 1061214-06-9 | Details |
| Celecoxib Impurity 1 | C17H14F3N3O2S | 170569-99-0 | Details |
| Celecoxib Impurity 5 | C17H14F3N3O3S | 170571-00-3 | Details |
| Celecoxib Impurity 3（Celecoxib EP Impurity A） | C17H14F3N3O2S | 170570-01-1 | Details |
| Hydrochlorothiazide | C7H8ClN3O4S2 | 58-93-5 | Details |
| Celecoxib Impurity 7 | C17H16F3N3O3S | 2629980-83-0 | Details |
| Celecoxib Impurity 16 | C8H8F3N3O3S | 915280-81-8 | Details |
| Amylmetacresol | C6H8ClN3O4S2 | 121-30-2 | Details |
| Celecoxib Impurity 8 | C11H9F3N2 | 26974-15-2 | Details |
| Salmeterol Impurity 5（Salmeterol EP Impurity D ） | C34H47NO7 | 1391052-04-2 | Details |
| Salmeterol Impurity 6（Salmeterol EP Impurity E ） | C25H37NO4 | 108928-81-0 | Details |
| Celecoxib Impurity 18 | C17H15F3N2O3S | 1061214-09-2 | Details |
| Diclofenac Impurity 1（Diclofenac EP Impurity D） | C14H11BrClNO2 | 127792-23-8 | Details |
| Celecoxib Impurity 9 | C11H9F3O2 | 53764-99-1 | Details |
| Hydrochlorothiazide Impurity 1 | C7H7Cl2N3O4S2 | 5233-42-1 | Details |
| Celecoxib Impurity 4（Celecoxib EP Impurity B） | C17H14F3N3O2S | 331943-04-5 | Details |
| Hydrochlorothiazide Impurity 2 | C8H5ClN2 | 5784-45-2 | Details |
| Celecoxib Impurity 2 | C17H12F3N3O4S | 170571-01-4 | Details |
| Salmeterol Impurity 7（Salmeterol EP Impurity F ） | C25H37NO3 | 1391054-40-2 | Details |
| Salmeterol Impurity 8（Salmeterol EP Impurity G ） | C50H72N2O7 | 1391051-88-9 | Details |
| Sorafenib | C21H16ClF3N4O3.C7H8O3S | 475207-59-1 | Details |
| Sorafenib Impurity 1 | C16H17N3O4 | 2206827-12-3 | Details |
| Sorafenib Impurity 14 | C21H17F3N4O3 | 1285533-84-7 | Details |
| Sorafenib Impurity 13 | C14H14N4O3 | 1129683-88-0 | Details |
| Sorafenib Impurity 8 | C7H5ClF3N | 320-51-4 | Details |
| Sorafenib Impurity 9 | C13H13N3O2 | 284462-37-9 | Details |
| Regorafenib Impurity 25 | C10H9ClF3NO2 | 18585-06-3 | Details |
| Sorafenib Impurity 31 | C20H13ClF3N3O4 | 1012058-78-4 | Details |
| Sorafenib Impurity 15 | C8H6ClF3N2O | 343247-69-8 | Details |
| Sorafenib Impurity 16 | C21H16ClF3N4O3 | 1431697-81-2 | Details |
| Sorafenib Impurity 24 | C7H3ClF3NO2 | 39974-35-1 | Details |
| Sorafenib Impurity 27（Sorafenib N-Oxide） | C21H16ClF3N4O4 | 583840-03-3 | Details |
| Sorafenib Impurity 30 | C7H7ClN2O | 845306-04-9 | Details |
| Sorafenib Impurity 26 | C3H4N2 | 288-32-4 | Details |
| Sorafenib Impurity 20 | C7H8N2O | 6144-78-1 | Details |
| Sorafenib Impurity 12 | C17H19N3O4 | 2206827-14-5 | Details |
| Sorafenib Impurity 11 | C13H12N2O2 | 2004659-85-0 | Details |
| Darifenacin | C28H31BrN2O2 | 133099-07-7 | Details |
| Vinpocetine Impurity 6 | C22H26N2O2 | 42971-12-0 | Details |
| Enzalutamide Impurity 11 | C21H18F4N4O3S | 2030242-21-6 | Details |
| Vinpocetine Impurity 5 | C22H26N2O2 | 85647-43-4 | Details |
| Vinpocetine Impurity 7 | C22H26N2O2 | 77549-94-1 | Details |
| Darifenacin Impurity 1 | C28H31BrN2O2 | 1092800-15-1 | Details |
| Dutasteride Impurity 3 | C20H29NO3 | 103335-41-7 | Details |
| Dutasteride Impurity 5 | C27H32F6N2O2 | 164656-22-8 | Details |
| Dutasteride Impurity 2 | C27H30F6N2O2 | 957229-52-6 | Details |
| Dabigatran Impurity 8 | C19H20N4O4 | 1642853-67-5 | Details |
| Irbesartan Impurity 1（Irbesartan EP Impurity A） | C25H30N6O2 | 748812-53-5 | Details |
| Dabigatran Impurity 17 | C18H22N4O3 | 212322-56-0 | Details |
| Dutasteride | C27H30F6N2O2 | 164656-23-9 | Details |
| Darifenacin Impurity 2 | C28H29BrN2O2 | 943034-52-4 | Details |
| Dabigatran Impurity 6 | C34H41N7O5 | 1610758-22-9 | Details |
| Dabigatran Impurity 9 | C26H33N5O4 | 1408238-36-7 | Details |
| Irbesartan | C25H28N6O | 138402-11-6 | Details |
| Dabigatran Impurity 2 | C32H37N7O5 | 212321-78-3 | Details |
| Dutasteride Impurity 6（Dutasteride EP Impurity C） | C21H31NO3 | 157307-36-3 | Details |
| Dabigatran Impurity 14 | C27H28N6O4 | 1422435-41-3 | Details |
| Dabigatran Impurity 4 | C34H40N6O6 | 1408238-40-3 | Details |
| Dabigatran | C25H25N7O3 | 211914-51-1 | Details |
| Dabigatran Etexilate | C34H41N7O5 | 211915-06-9 | Details |
| Enzalutamide Impurity 5 | C21H17F3N4O2S | 915087-16-0 | Details |
| Dabigatran Impurity 10 | C27H26N6O3 | 211915-84-3 | Details |
| Dabigatran Impurity 16 | C27H29N7O3 | 429658-95-7 | Details |
| Dutasteride Impurity 1（Dutasteride EP Impurity E） | C27H30F6N2O2 | 2102935-76-0 | Details |
| Dabigatran Impurity 15 | C34H41N7O6 | 1381757-44-3 | Details |
| Dutasteride Impurity 10 | C19H29NO3 | 103335-55-3 | Details |
| Dutasteride Impurity 7（Dutasteride EP Impurity F） | C27H31ClF6N2O2 | 1365545-42-1 | Details |
| Dabigatran Impurity 12 | C33H39N7O5 | 211915-00-3 | Details |
| Dabigatran Impurity 5 | C34H41N7O5 | 2225986-95-6 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 | ||||